Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_assertion type Assertion NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_head.
- NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_assertion description "[Our findings demonstrate for the first time that Hsp27 knockdown enhances the cytotoxic effects of radiotherapy in vivo and provide preclinical proof of principle for clinical trials using Hsp27 antisense technology in the treatment of patients with HNSCC radioresistant cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_provenance.
- NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_assertion evidence source_evidence_literature NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_provenance.
- NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_assertion SIO_000772 19436268 NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_provenance.
- NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_assertion wasDerivedFrom befree-20140225 NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_provenance.
- NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_assertion wasGeneratedBy ECO_0000203 NP423895.RATe-kcbW2cEN2VpKpVBpzRhEX-wd4Zt-rfV8uhgKAy_s130_provenance.